Validation of Recently Proposed Colorectal Cancer Susceptibility Gene Variants in an Analysis of Families and Patients-a Systematic Review.

High-throughput sequencing analysis has accelerated searches for genes associated with risk for colorectal cancer (CRC); germline mutations in NTHL1, RPS20, FANCM, FAN1, TP53, BUB1, BUB3, LRP6, and PTPN12 have been recently proposed to increase CRC risk. We attempted to validate the association betw...

Cijeli opis

Bibliografski detalji
Glavni autori: Broderick, P, Dobbins, S, Chubb, D, Kinnersley, B, Dunlop, M, Tomlinson, I, Houlston, R
Format: Journal article
Jezik:English
Izdano: Elsevier 2016
_version_ 1826298528153993216
author Broderick, P
Dobbins, S
Chubb, D
Kinnersley, B
Dunlop, M
Tomlinson, I
Houlston, R
author_facet Broderick, P
Dobbins, S
Chubb, D
Kinnersley, B
Dunlop, M
Tomlinson, I
Houlston, R
author_sort Broderick, P
collection OXFORD
description High-throughput sequencing analysis has accelerated searches for genes associated with risk for colorectal cancer (CRC); germline mutations in NTHL1, RPS20, FANCM, FAN1, TP53, BUB1, BUB3, LRP6, and PTPN12 have been recently proposed to increase CRC risk. We attempted to validate the association between variants in these genes and development of CRC in a systematic review of 11 publications, using sequence data from 863 familial CRC cases and 1604 individuals without CRC (controls). All cases were diagnosed at an age of 55 years or younger and did not carry mutations in an established CRC predisposition gene. We found sufficient evidence for NTHL1 to be considered a CRC predisposition gene-members of 3 unrelated Dutch families were homozygous for inactivating p.Gln90Ter mutations; a Canadian woman with polyposis, CRC, and multiple tumors was reported to be heterozygous for the inactivating NTHL1 p.Gln90Ter/c.709+1G>A mutations; and a man with polyposis was reported to carry p.Gln90Ter/p.Gln287Ter; whereas no inactivating homozygous or compound heterozygous mutations were detected in controls. Variants that disrupted RPS20 were detected in a Finnish family with early-onset CRC (p.Val50SerfsTer23), a 39-year old individual with metachronous CRC (p.Leu61GlufsTer11 mutation), and a 41-year-old individual with CRC (missense p.Val54Leu), but not in controls. We therefore found published evidence to support the association between variants in NTHL1 and RPS20 with CRC, but not of other recently reported CRC susceptibility variants. We urge the research community to adopt rigorous statistical and biological approaches coupled with independent replication before making claims of pathogenicity.
first_indexed 2024-03-07T04:48:14Z
format Journal article
id oxford-uuid:d40fb7b7-9df5-4b50-a757-86ad968c37e1
institution University of Oxford
language English
last_indexed 2024-03-07T04:48:14Z
publishDate 2016
publisher Elsevier
record_format dspace
spelling oxford-uuid:d40fb7b7-9df5-4b50-a757-86ad968c37e12022-03-27T08:15:45ZValidation of Recently Proposed Colorectal Cancer Susceptibility Gene Variants in an Analysis of Families and Patients-a Systematic Review.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:d40fb7b7-9df5-4b50-a757-86ad968c37e1EnglishSymplectic Elements at OxfordElsevier2016Broderick, PDobbins, SChubb, DKinnersley, BDunlop, MTomlinson, IHoulston, RHigh-throughput sequencing analysis has accelerated searches for genes associated with risk for colorectal cancer (CRC); germline mutations in NTHL1, RPS20, FANCM, FAN1, TP53, BUB1, BUB3, LRP6, and PTPN12 have been recently proposed to increase CRC risk. We attempted to validate the association between variants in these genes and development of CRC in a systematic review of 11 publications, using sequence data from 863 familial CRC cases and 1604 individuals without CRC (controls). All cases were diagnosed at an age of 55 years or younger and did not carry mutations in an established CRC predisposition gene. We found sufficient evidence for NTHL1 to be considered a CRC predisposition gene-members of 3 unrelated Dutch families were homozygous for inactivating p.Gln90Ter mutations; a Canadian woman with polyposis, CRC, and multiple tumors was reported to be heterozygous for the inactivating NTHL1 p.Gln90Ter/c.709+1G>A mutations; and a man with polyposis was reported to carry p.Gln90Ter/p.Gln287Ter; whereas no inactivating homozygous or compound heterozygous mutations were detected in controls. Variants that disrupted RPS20 were detected in a Finnish family with early-onset CRC (p.Val50SerfsTer23), a 39-year old individual with metachronous CRC (p.Leu61GlufsTer11 mutation), and a 41-year-old individual with CRC (missense p.Val54Leu), but not in controls. We therefore found published evidence to support the association between variants in NTHL1 and RPS20 with CRC, but not of other recently reported CRC susceptibility variants. We urge the research community to adopt rigorous statistical and biological approaches coupled with independent replication before making claims of pathogenicity.
spellingShingle Broderick, P
Dobbins, S
Chubb, D
Kinnersley, B
Dunlop, M
Tomlinson, I
Houlston, R
Validation of Recently Proposed Colorectal Cancer Susceptibility Gene Variants in an Analysis of Families and Patients-a Systematic Review.
title Validation of Recently Proposed Colorectal Cancer Susceptibility Gene Variants in an Analysis of Families and Patients-a Systematic Review.
title_full Validation of Recently Proposed Colorectal Cancer Susceptibility Gene Variants in an Analysis of Families and Patients-a Systematic Review.
title_fullStr Validation of Recently Proposed Colorectal Cancer Susceptibility Gene Variants in an Analysis of Families and Patients-a Systematic Review.
title_full_unstemmed Validation of Recently Proposed Colorectal Cancer Susceptibility Gene Variants in an Analysis of Families and Patients-a Systematic Review.
title_short Validation of Recently Proposed Colorectal Cancer Susceptibility Gene Variants in an Analysis of Families and Patients-a Systematic Review.
title_sort validation of recently proposed colorectal cancer susceptibility gene variants in an analysis of families and patients a systematic review
work_keys_str_mv AT broderickp validationofrecentlyproposedcolorectalcancersusceptibilitygenevariantsinananalysisoffamiliesandpatientsasystematicreview
AT dobbinss validationofrecentlyproposedcolorectalcancersusceptibilitygenevariantsinananalysisoffamiliesandpatientsasystematicreview
AT chubbd validationofrecentlyproposedcolorectalcancersusceptibilitygenevariantsinananalysisoffamiliesandpatientsasystematicreview
AT kinnersleyb validationofrecentlyproposedcolorectalcancersusceptibilitygenevariantsinananalysisoffamiliesandpatientsasystematicreview
AT dunlopm validationofrecentlyproposedcolorectalcancersusceptibilitygenevariantsinananalysisoffamiliesandpatientsasystematicreview
AT tomlinsoni validationofrecentlyproposedcolorectalcancersusceptibilitygenevariantsinananalysisoffamiliesandpatientsasystematicreview
AT houlstonr validationofrecentlyproposedcolorectalcancersusceptibilitygenevariantsinananalysisoffamiliesandpatientsasystematicreview